CVS Caremark will expand the use of lower-cost biosimilars across multiple therapeutic categories effective July 1.
CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and Tymlos. Like Humira and its biosimilars, Prolia is a specialty drug ...